513 related articles for article (PubMed ID: 27083050)
21. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
[TBL] [Abstract][Full Text] [Related]
22. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
Peta E; Cappellesso R; Masi G; Sinigaglia A; Trevisan M; Grassi A; Di Camillo B; Vassarotto E; Fassina A; Palù G; Barzon L
Hum Pathol; 2017 Mar; 61():33-40. PubMed ID: 27818285
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 E6 containing SiHa cells.
Huang H; Huang SY; Chen TT; Chen JC; Chiou CL; Huang TM
J Cell Biochem; 2004 Mar; 91(4):756-65. PubMed ID: 14991767
[TBL] [Abstract][Full Text] [Related]
25. Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.
Rataj O; Haedicke-Jarboui J; Stubenrauch F; Iftner T
Int J Cancer; 2019 May; 144(9):2330-2338. PubMed ID: 30421459
[TBL] [Abstract][Full Text] [Related]
26. Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells.
Bonetta AC; Mailly L; Robinet E; Travé G; Masson M; Deryckere F
Biochem Biophys Res Commun; 2015 Oct; 465(4):658-64. PubMed ID: 26241675
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.
Fan R; Hou WJ; Zhao YJ; Liu SL; Qiu XS; Wang EH; Wu GP
Tumour Biol; 2016 Apr; 37(4):4655-63. PubMed ID: 26508030
[TBL] [Abstract][Full Text] [Related]
28. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
29. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
30. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
Harden ME; Munger K
Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850
[TBL] [Abstract][Full Text] [Related]
31. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown.
Diaz D; Santander MA; Chavez JA
Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553
[TBL] [Abstract][Full Text] [Related]
32. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.
Dogra S; Bandi S; Viswanathan P; Gupta S
Cancer Lett; 2015 Jan; 356(2 Pt B):953-61. PubMed ID: 25444910
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway.
Wang X; Zhang Z; Cao H; Niu W; Li M; Xi X; Wang J
J Med Virol; 2017 Oct; 89(10):1852-1860. PubMed ID: 28480962
[TBL] [Abstract][Full Text] [Related]
35. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer.
Wu DW; Tsai LH; Chen PM; Lee MC; Wang L; Chen CY; Cheng YW; Lee H
Am J Pathol; 2012 Nov; 181(5):1796-806. PubMed ID: 22982189
[TBL] [Abstract][Full Text] [Related]
36. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
[TBL] [Abstract][Full Text] [Related]
37. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
38. A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.
Celegato M; Messa L; Goracci L; Mercorelli B; Bertagnin C; Spyrakis F; Suarez I; Cousido-Siah A; Travé G; Banks L; Cruciani G; Palù G; Loregian A
Cancer Lett; 2020 Feb; 470():115-125. PubMed ID: 31693922
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.
DasGupta T; Nweze EI; Yue H; Wang L; Jin J; Ghosh SK; Kawsar HI; Zender C; Androphy EJ; Weinberg A; McCormick TS; Jin G
Oncotarget; 2016 May; 7(19):27430-44. PubMed ID: 27034006
[TBL] [Abstract][Full Text] [Related]
40. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
